After a highly successful 2024, highlighted by key transactions and significant team developments, we are thrilled to announce the appointment of Michael Bälz as Managing Director in our Munich office. Michael will be instrumental in advancing our healthcare expertise as he assumes the role of Head of Healthcare in Germany. This strategic addition further strengthens our leadership team in Germany.
He brings extensive sector-specific expertise gained during his time with UniCredit's advisory and financing solutions team. As a Managing Director, Michael led M&A transactions, with a particular focus on healthcare and business services. Prior to this, he worked with Rothschild in its global advisory division, based in Frankfurt and London.
Michael has advised on numerous transactions during his career, among others:
- The sale of a radiological MVZ group in Halle to Evidia
- The sale of REALEYES to Zentrum Gesundheit
- The sale of imes-icore to Ardian
- The sale of Dermatologikum Hamburg to ECM
- The sale of Siemens Gebäudemanangement und -Services to Apleona
With an impressive track record, Michael brings invaluable sector expertise that will strengthen our presence in the DACH region and enhance the capabilities of our healthcare team, both locally and internationally. His leadership will be instrumental in further elevating our management team in Germany, as we work together to build on Clearwater’s continued success and solidify our market position in the region.
"With Michael as Head of Healthcare in Germany, we are poised to further expand our healthcare capabilities in the region and become one of the leading M&A advisers in this field."
Axel Oltmann, Managing Partner, commented:
“With the addition of Michael, we are excited to welcome a highly respected and experienced sector expert in the healthcare space. This appointment marks a significant milestone in the strategic development of our positioning in the sector. The healthcare market is dynamic and complex, shaped by a range of different factors such as demographic change, technological innovation, increasing digitalisation, rising costs, new regulatory frameworks, and a growing focus on prevention and health management. Alongside a rising number of succession situations, these trends will continue to drive the market in the future, and this is why we expect strong growth in activity. With Michael as Head of Healthcare in Germany, we are poised to further expand our healthcare capabilities in the region, and working alongside the international team at Clearwater, to become one of the leading M&A advisers in this field.”
Michael Bälz, Managing Director and Head of Healthcare in Germany, added:
“I am very much looking forward to working with my colleagues at Clearwater and further expanding our position as a leading M&A adviser in the healthcare sector. With extensive experience in the healthcare space and a deep understanding of the diverse challenges and opportunities within this dynamic market, I am committed to helping our clients achieve their strategic goals and connect them with attractive growth opportunities.”